<p>Subpopulations and intermediate outcome measures in COPD study (SPIROMICS) supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from subjects with COPD for the purpose  of identifying subpopulations and intermediate outcome measures. It is funded by the National Heart, Lung, and Blood Institute and is coordinated by</p>

SPIROMICS Genetic and Genomics

Pulmonary Disease, Chronic Obstructive study with SNP Genotypes (Array) data on dbGaP (2,611 participants)